Cholinergic System Flashcards

1
Q

Cholinergic receptors

A

Muscarinic (GPCR)
- m1= neurons, CNS, gastric parietal cells (excitation, Gq, IP3,DAG)
-m2= heart, nerves, smooth muscle (inhibition, Gi, decreased camp, increased k+)
-m3= glands, smooth muscle, endothelium (excitation, Gq, IP3, DAG)
Nicotinic (ligand gated ion channels)
-Nn= a and beta subunit
-Nm= a2byd - pentamer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Transmitter in cholinergic neuron

A

Acetylcholine

  • choline from diet or serine
  • acetyl-CoA from glycolysis and TCA cycle, or fat from beta oxidation, can come from proteins in case of starvation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Main cholinergic transmission sites and receptors

A
  1. CNS= m1-m5
  2. Autonomic ganglion = m1, m2 and Nn (both parasymp and symp)
  3. NMJ = Nn
  4. Parasympathetic postganglionic nerves= m1-m3
  5. Some symp. Postganglionic nerves = m
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Consequence of cholinergic activation

A

Eye: contraction (Miosis) and lacrimation - m3

Salivary glands: salivation - m3

Lungs: bronchoconstriction and increases secretion - m3

Heart: SA,AV- negative chronotropic and dromotropic, bradycardia and decreased contraction - m2

Vessels: contraction - m3, relaxation-NO endothelium - m3 (m2)

Smooth muscle: contract/increases motility by m3 and m1, relaxation of sphincters by m3 and m1

Bladder: urination - m3

Skeletal muscles: contraction by Nm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Presynaptic stimulation

A
  1. Potassium channel blockers/.
    - 4-aminopyridine(fampiridine) used in ms patients. Would cause severe depolarization all over leading to CNS cramps, ph regulation troubles and cardiac arrest, it can also induce epilepsy
  2. Increase in calcium levels
    - theoretical option, not practical
    - non specific
    - toxic, causes cell death
  3. Alpha- latrotoxin
    - spider - black widow
    - toxic compound
    - not specific for parasympathetic
    - calcium modulator, increase ca2+
  4. Activation of stimulatory presynaptic receptors
    - m1, b2, at1, some prostaglandins
    - depends on pathway
    - nmj; a or beta adrenergic
  5. Inhibition of inhibitory presynaptic receptors
    - m2, a2, d2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presynaptic inhibition

A
  1. Tetrodotoxin
    - block vgsc
    - not specific for parasympathetic
    - use: LAs
    - systemic action is highly toxic
  2. Omega-conitixin
    - puffer fish
    - inhibit ACh release
  3. Botulinum toxin
    - inhibit release if ACh to synaptic cleft, act on SNARE proteins
    - used therapeutically
    - indication: migraine, strabismus, dystonia
    - paralysis of skeletal muscle; few months
  4. Vesamicol
    - action on VAT to inhibit storage of ACh
  5. Hemicholinium
    - inhibit choline reuptake
    - no therapeutic use
  6. Resirpin = experimental
  7. Inhibition of excitatory presynaptic receptors
  8. Activation of inhibitory presynaptic receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Postsynaptic stimulation groups

A
  1. Direct acting - act on receptors to stimulate them
    - choline esters (ACh, methacholine, carbachol, betanechol)
    - alkaloids ( muscarine, pilocarpine, arecholine, and cevimeline, nicotine, lobeline, coniine, varenicline, succinylchokine)
  2. Indirect acting - act to increase ACh in synaptic cleft
    - alcohols = reversible and competitive (edrophonium, tacrine, donepezil, galantamine)
    - carbamates = non-competitive, reversible (physostigmine/eserin, rivastigmine, neostigmine, pyridostigmine, ambenonium, demecarium)
  • organophosphates =irreversible inhibition (ecothiophate, tabun, soman, sarin, vx, parathion, malathion, diazinon, diamethoate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Choline esters

A

Acetylcholine
Methacholine
Carbachol
Betanechol

All are quaternary amides, poor GI absorption, poor CNS penetration, direct acting and excreted by kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acetylcholine

A
  • main physiologic compound
  • not used for treatment due to rapid degradation by AChE
  • can be used in ophthalmology
  • both nicotinic and muscarinic affinity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Methachol

A
  • ACh + methyl group
  • specific for muscarinic receptors
  • indication: diagnosis of bronchial hyperactivity
  • slowly degraded by cholinesterase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Carbachol

A
  • ACh + amine group
  • resistant to cholinesterase
  • long lasting pharmacon
  • non-selective
  • indication: glaucoma, eye surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Betanechol

A
  • resistant to cholinesterase
  • selective for muscarinic receptors
  • long lasting pharmacon
  • indication: GI atony, bladder atony, perioperative urinary retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alkaloids - direct acting

A
  1. Natural compounds
    - muscarine
    - pilocarpine
    - arecholine
    - nicotine
    - lobeline
    - coniine
  2. Synthetic compounds
    - cevimeline
    - varenicline
    - succinylcholine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Muscarine

A
  • direct acting alkaloid
  • selective for muscarinic receptors
  • 4 amine
  • originates from amanita muscaria
  • toxic, not used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pilocarpine

A
  • direct acting alkaloid
  • selective for muscarinic receptors
  • 3 amine
  • indication: glaucoma, xerostomia, sjögren
  • quick acting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Arecholine

A
  • direct acting alkaloid
  • not selective, both m and n
  • 3 amine
  • addictive drug - not used
  • euphoric effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cevimeline

A
  • direct acting alkaloid
  • synthetic
  • 3 amine
  • m3 selectivity
  • indication: xerostomia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nicotine

A
  • direct acting alkaloid
  • 3 amine
  • selective for nicotinic receptors
  • indication: poison, smoke cessation
  • note: ganglionic stimulant - small dose
19
Q

Lobeline

A
  • direct acting alkaloid
  • high dose is toxic
  • selective for nicotinic receptors
  • small dose = smoke cessation
20
Q

Coniine

A
  • direct acting alkaloid
  • selective for nicotinic receptors
  • highly toxic
21
Q

Varenicline

A
  • direct acting alkaloid
  • synthetic
  • partial agonist on nicotinic receptors
  • long acting, 24h half-life
  • indication; smoke cessation
  • note: ganglionic stimulant
22
Q

Succinylcholine

A
  • direct acting alkaloid
  • synthetic
  • 4 amine
  • selective for Nm
  • indication; endotracheal intubation
  • note; ganglionic stimulant
23
Q

Cholinesterase inhibitors

- alcohols

A

Edrophonium
Tacrine
Donepezil
Galantamine

24
Q

Edrophonium

A
  • reversible cholinesterase inhibitor
  • alcohol
  • 4 amine
  • water soluble
  • dissociates quickly
  • half- life: 0.5-2 h
  • indication: myasthenia gravis diagnosis, overcome the effect of non-depolarizing muscle relaxant (antidote)
25
Q

Tacrine

A
reversible cholinesterase inhibitor
Alcohol 
Lipid soluble 
3 amine 
Indication: Alzheimer’s 
Hepatotoxic
26
Q

Donepezil

A
  • reversible cholinesterase inhibitor
  • alcohol
  • 3 amine
  • lipid soluble
  • half-life: 50-90h /3 days
  • indication: Alzheimer’s
  • note: hepatic metabolism
27
Q

Galantamine

A
  • reversible cholinesterase inhibitor
  • alcohol
  • lipid soluble
  • half-life: 5-7h
    Indication: Alzheimer’s
    Note: hepatic metabolism 75%
28
Q

Cholinesterase inhibitors

- carbamates

A
Physostigmine/eserin
Rivastigmine
Neostigmine
Pyridostigmine
Ambenonium
Demecarium
29
Q

Physostigmine/eserin

A

carbamate

  • non- competitive cholinesterase inhibitor
  • reversible but takes time
  • 3 amine
  • lipid soluble
  • short acting; 0.5-2h
  • indication: glaucoma, atropine poison
30
Q

Rivastigmine

A

carbamate

  • non- competitive cholinesterase inhibitor
  • reversible but takes time
  • 3 amine, lipid soluble
  • metabolized by AChE and BChE
  • long acting: 9 h
  • indication; Alzheimer’s and dementia
31
Q

Neostigmine

A

carbamate

  • non- competitive cholinesterase inhibitor
  • reversible but takes time
  • 4 amine, water soluble
  • short acting: 0.5-2 h
  • indication; intestine and bladder atony, myasthenia gravis, antagonize non-depolarizing muscle relaxant and urinary retention
32
Q

Pyridostigmine

A

carbamate

  • non- competitive cholinesterase inhibitor
  • reversible but takes time
  • 4 amine, water soluble
  • long acting: 3-6 h
  • indication: myasthenia gravis, pseudoparalytica intestinal atony, atonic obstipation
33
Q

Ambenonium

A
  • non- competitive cholinesterase inhibitor
  • reversible but takes time
  • 4 amine, water soluble
  • long lasting: 4-8 h
    Indication; myasthenia gravis
  • carbamate
34
Q

Demecarium

A

carbamate

  • non-competitive cholinesterase inhibitor
  • reversible but takes time
  • 4 amine, water soluble
  • long acting: 4-6 h
  • indication: glaucoma
35
Q

Organophosphate

A
  • Irreversible inhibition of cholinesterase
  • ecothiophate - glaucoma
  • tabun, soman, sarin, vx = nerve agent used as war gases
  • parathion, malathion, diazinon, diamethoate - insecticides
36
Q

Therapeutic use of cholinomimetics/stimulation of nicotinic/muscarinic receptors

A
  • glaucoma
  • post op and neurogenic lieus, urinary retention
  • myasthenia gravis
  • reversing the action of neuromuscular blocking agents
  • Alzheimer’s
  • sjögren
37
Q

Adverse effects of cholinomimetics

A

Dumbbels

  • diarrhea
  • urination
  • miosis
  • bronchospasm
  • bradycardia
  • excitation
  • lacrimation
  • secretion/salivation/sweat
38
Q

Postsynaptic inhibition

A

Parasympatholytics - muscarinic antagonists

  • tropeins
  • non-tropeins

Nicotinic antagonists - ganglionic blockers

  • 4 compounds; tetraethylamminum and hexamethonium
  • 3 compounds; mecamylamine, trimetaphan

Nicotinic antagonists - skeletal muscle relaxants

39
Q

Tropeins

A

Parasympatholytics - m antagonists

  • atropine
  • scopolamine/hyoscin
  • homatropine
  • benzotrapine (more soluble than atropine)
  • methylatropine
  • ipratropium
  • tiotropiun
40
Q

Non-tropines

A

Muscarinic antagonists

Procyclidine 
- 3 amine 
- Parkinson’s 
Biperiden
- 3 amine 
- Parkinson’s 
Cyclopentolate
- 3 amine
- pupil dilator 
Tropicamide
- 3 amine 
- pupil dilator 
Oxybutidine 
- 3 amine 
- overactive bladder
Tolterodine
- 3 amine 
- overactive bladder
Solifenacin m3
- 3 amine, overactive bladder
Darifenacine m3
- overactive bladder
Aclindium 
- 4 amine 
- copd, asthma
Glycopyrronium
- 4 amine
41
Q

Clinical use of parasympatholytics

A
Pupil dilation 
Bronchial asthma 
Bradycardia, AV block grade 1
Pre or intraoperative medication 
Antagonize parasympathomimetics effect of        —cholinesterase inhibition 
Peptic ulcer 
Incontinence 
Diarrhea
Abdominal cramps
Parkinson’s 
Organophosphate poisoning
42
Q

Adverse effects of parasympatholytics

A

Abcd

Atropine fever
Blurred vision
Constipation
Dry mouth

43
Q

Atropine

A
  • m antagonist
  • source: atropa belladonna
  • 3 amine
  • effect: 2-3h, myadriasis 7-10 days!
  • dose; 0.3-0.5 mg
  • lethal dose; 100 mg, 2mg infants
    Indication: eye drops, bradycardia, AV block grade 1, gi/bladder/urinary cramps, cholinomimetics poison
    CNS effects; antiemetic effects/motion sickness, restlessness, dyskinesia, raging, hallucinations, epileptiform convulsions, coma and death
    Signs of atropine overdose; hot as a hare, blind as a bat, dry as a cracker, red as a beet and mad as a hatter
44
Q

Scopolamine

A
  • m antagonist
  • potato family
  • 3 amine
  • 2-3 h, myadrisis 3-7 days.
  • dose; 0.2-0.4 mg
  • lethal dose: 500 mg
  • indication: motion sickness. Antiemetic